11th January 2022
- 0 comments
Brainomix, the AI-powered medtech solutions company, has closed a series B financing round, raising £16M ($21.2M) to fund its expansion into new markets and new therapeutic indications, including lung fibrosis and cancer. This investment will build on the proven success of the company’s tech platform in stroke and enable value-generating pharmaceutical partnerships to improve clinical trial success, foster broader adoption of existing therapies in the new indications, and improve patient outcomes.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.